CartilaGen

Manufacturing · 1-10 Employees

View Company Info for Free

Overview

Phone Number

(319) 384-2741

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About CartilaGen

CartilaGen is focused on developing CG-001, a novel therapeutic option aimed at preventing post-traumatic osteoarthritis (PTOA) in patients with ankle fractures and other traumatic joint injuries. The product is designed to be administered during standard surgical procedures, targeting the biological triggers of PTOA to protect cartilage and preserve mobility. The company aims to provide orthopedic surgeons and trauma specialists with a simple yet effective solution that integrates seamlessly into surgical workflows. Additionally, CG-001 presents significant market potential for investors, with strong intellectual property protection and a clear unmet need in both civilian and military injury settings.Explore more
CartilaGen's Social MediaPopular SearchesCartilagen LLCCartilaGen IncCartilaGenSIC Code 28,283NAICS Code 32,325Show more

CartilaGen Org Chart

PhoneEmail
AH

Interim Chief Executive Officer, Amasa Therap...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is CartilaGen your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to CartilaGen

Compare insights from companies similar to CartilaGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

CartilaGen

<$5M
1-10
Private
-
2015
AH
Arthur HillerInterim CEO, Amasa Therapeutics and CartilaGen
$9.7M
11-50
Public
-
2009
Christopher Volker, Chief Financial Officer at NeuroOne
Christopher VolkerChief Financial Officer
<$5M
11-50
Private
-
1996
N/A
<$5M
1-10
Private
-
-
TP
Tamyka PenglaseCustomer & Support Administrator
<$5M
1-10
Private
-
2006
<$5M
11-50
Public
$57.4M
2014
WT
Wyatt ToleDirector Clinical Flow Cytometry
11-50
Public
$55.9M
2000
Chaim Lebovits, President & Chief Executive Officer at Brainstorm Cell Therapeutics
Chaim LebovitsPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

CartilaGen is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

CartilaGen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CartilaGen.

CartilaGen Tech Stack

CartilaGen News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding CartilaGen

What is CartilaGen's official website?
CartilaGen's official website is www.cartilagen.com
What is CartilaGen's Revenue?
CartilaGen's revenue is <$5 Million
What is CartilaGen's SIC code?
CartilaGen's SIC: 28,283
What is CartilaGen's NAICS code?
CartilaGen's NAICS: 32,325
How many employees does CartilaGen have?
CartilaGen has 1-10 employees
What industry does CartilaGen belong to?
CartilaGen is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is CartilaGen competition?
CartilaGen top competitors include: NeuroOne, NuroKor, Global Life Science Ventures, Cytonics
What technology does CartilaGen use?
Some of the popular technologies that CartilaGen uses are: Cloudflare CDN, Google Cloud Web Serving, Google Cloud Platform, Microsoft 365
How do I contact CartilaGen?
CartilaGen contact info: Phone number: (319) 384-2741 Website: www.cartilagen.com
What does CartilaGen do?

CartilaGen is focused on developing CG-001, a novel therapeutic option aimed at preventing post-traumatic osteoarthritis (PTOA) in patients with ankle fractures and other traumatic joint injuries. The product is designed to be administered during standard surgical procedures, targeting the biological triggers of PTOA to protect cartilage and preser... ve mobility. The company aims to provide orthopedic surgeons and trauma specialists with a simple yet effective solution that integrates seamlessly into surgical workflows. Additionally, CG-001 presents significant market potential for investors, with strong intellectual property protection and a clear unmet need in both civilian and military injury settings.Read More

What are CartilaGen social media links?
CartilaGen Linkedin page CartilaGen Twitter page CartilaGen Facebook page
Is CartilaGen a public company?
CartilaGen is private company therefore does not currently have an official ticker symbol
See more information about CartilaGen

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.